Neurocrine Bioscience buy Canaccord Genuity Group Inc.
Start price
30.03.23
/
50%
€89.90
Target price
30.03.24
€120.95
Performance (%)
47.22%
End price
01.04.24
€132.35
Summary
This prediction ended on 01.04.24 with a price of €132.35. With a performance of 47.22% the BUY prediction by Canaccord_Genuity_Gr was a big success. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -2.546% | -2.546% | 7.429% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $132.00 price target on the stock, up previously from $124.00.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten